Biotech & Health Tech
STAT+: Pharmalittle: We’re reading about CVS plans to split up, FDA inspections in India and China and more
The Trump administration will survey key components of pharmaceutical production in order to identify domestic supply chain vulnerabilities.
The Trump administration will survey key components of pharmaceutical production in order to identify domestic supply chain vulnerabilities.
This is a summary of the story. Read the full article at Stat News (Biotech & Health Tech) ↗